Investor Overview

Press Releases

Date	Title and Summary	View
3/22/18	Orthofix Receives FDA 510(k) Clearance of G-Beam Fusion Beaming System	Additional Formats
3/15/18	Orthofix Announces Agreement to Acquire Spinal Kinetics	Additional Formats
3/15/18	Orthofix Announces Agreement to Acquire Spinal Kinetics	Additional Formats
3/13/18	Orthofix Announces Appointment of John Sicard to Board of Directors	Additional Formats
3/7/18	Orthofix Secures FDA and CE Mark Approvals for New PhysioStim Bone Growth Stimulators	Additional Formats
3/5/18	Publication of Data Further Confirms Effectiveness of the Orthofix Cervical-Stim Device in Improving Fusion Rates	Additional Formats
2/26/18	Orthofix International Reports Fourth Quarter and Fiscal 2017 Financial Results	Additional Formats
2/13/18	Orthofix Announces Initiation of Enrollment in Rotator Cuff Repair Study	Additional Formats
2/12/18	Orthofix Schedules Fourth Quarter and Fiscal 2017 Earnings Release and Conference Call for February 26, 2018	Additional Formats
2/6/18	Orthofix Announces 510(k) Clearance and US Limited Market Launch of FORZA XP Expandable Spacer System	Additional Formats

Investor Overview